First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer.
- Conditions
- First Posted Date
- 2010-05-24
- Last Posted Date
- 2019-02-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 47
- Registration Number
- NCT01129310
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Tomosynthesis in Screening Mammography
- Conditions
- Interventions
- First Posted Date
- 2010-03-15
- Last Posted Date
- 2016-03-11
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 500
- Registration Number
- NCT01086241
- Locations
- π¨π¦
Alberta Screen Test, Edmonton, Alberta, Canada
A Study to Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma
- First Posted Date
- 2010-02-09
- Last Posted Date
- 2019-08-22
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 94
- Registration Number
- NCT01065805
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Study of AntiCTLA4 in Patients With Unresectable or Metastatic Uveal Melanoma
- First Posted Date
- 2009-12-17
- Last Posted Date
- 2017-10-27
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 11
- Registration Number
- NCT01034787
- Locations
- π¨π¦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
π¨π¦Cross Cancer Institute, Edmonton, Alberta, Canada
π¨π¦Princess Margaret Hospital, Toronto, Ontario, Canada
A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect)
- Conditions
- First Posted Date
- 2009-11-16
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 42
- Registration Number
- NCT01014065
- Locations
- π¨π¦
University of Alberta/ Cross Cancer Institute, Edmonton, Alberta, Canada
Metabolism of Lipids in Advanced Cancer
- First Posted Date
- 2009-08-19
- Last Posted Date
- 2016-02-26
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 12
- Registration Number
- NCT00962234
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Observational Pilot Study of 18F-Sodium Fluoride (Na18F) Whole Body Positron Emission Tomography (PET) Scans for Imaging Bone
- First Posted Date
- 2009-06-17
- Last Posted Date
- 2024-06-12
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 645
- Registration Number
- NCT00922519
- Locations
- π¨π¦
Princess Margaret Hospital, Toronto, Ontario, Canada
π¨π¦St. Joseph's Healthcare, Hamilton, Ontario, Canada
π¨π¦Sunnybrook Health Services Centre, Toronto, Ontario, Canada
Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer
- Conditions
- First Posted Date
- 2009-05-22
- Last Posted Date
- 2016-02-22
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 2
- Registration Number
- NCT00907569
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer
- Conditions
- First Posted Date
- 2009-04-28
- Last Posted Date
- 2016-03-16
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 13
- Registration Number
- NCT00888823
- Locations
- π¨π¦
Tom Baker Cancer Center, Calgary, Alberta, Canada
π¨π¦Cross Cancer Institute, Edmonton, Alberta, Canada
The Effects of Exercise Training on the Health-related Fitness of Colon Cancer Survivors
- Conditions
- Interventions
- First Posted Date
- 2008-12-23
- Last Posted Date
- 2016-03-11
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 52
- Registration Number
- NCT00813540
- Locations
- π¨π¦
Cross Cancer Institue, Edmonton, Alberta, Canada